학술논문
WCN23-0405 AN ADAPTIVE, DOSE-EXPLORATION, PHASE 2 TRIAL EVALUATING EFFICACY AND SAFETY OF IPTACOPAN IN COMBINATION WITH STANDARD-OF-CARE WITH AND WITHOUT ORAL CORTICOSTEROIDS IN ACTIVE LUPUS NEPHRITIS
Document Type
Abstract
Author
Source
In Kidney International Reports March 2023 8(3) Supplement:S66-S66
Subject
Language
ISSN
2468-0249